Kelen
☆    

Brazil,
2020-06-29 20:51
(1829 d 20:37 ago)

Posting: # 21605
Views: 1,843
 

 Transdermal [Regulatives / Guidelines]

Post reply
Hi everyone,
In Brazil we are implementing the guideline about generic transdermal products and I have some doubts about the EMA Guideline.

(1) About the sensitisation and irritation test, is it dependent on how the medication is used or should it always be done as described in the guide, a patch every day even if the patch is to be used for more than 24 hours?

(2) Is a multiple dose study necessary if accumulation is observed or is there any other condition that would dispense this study with transdermal patches?

I would appreciate a lot any kind of help.
Thanks in advance!

Kelen
 
UA Flag
Activity
 Admin contact
23,426 posts in 4,929 threads, 1,682 registered users;
63 visitors (0 registered, 63 guests [including 13 identified bots]).
Forum time: 17:29 CEST (Europe/Vienna)

You can do one of two things; just shut up,
which is something I don’t find easy,
or learn an awful lot very fast,
which is what I tried to do.    Jane Fonda

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5